Interventional cardiologist| Basement Athlete|#TAVR| #CTOPCI | #CHIP#PTE

Joined June 2019
Photos and videos
Mark F. Sasse retweeted
What are the benefits of #IVUS-guided #DCB angioplasty in de novo lesions? 🤔 Check out the results of the ULTIMATE III trial in this issue of #JACCINT: bit.ly/3Whw0TJ
18
38
6,732
Mark F. Sasse retweeted
In patients undergoing valve-in-valve (ViV) interventions for failed surgical bioprosthetic valves, performing bioprosthetic valve fracture (BVF) after transcatheter heart valve (THV) implantation, compared to BVF performed before THV implantation or no BVF, resulted in better immediate hemodynamic performance and sustained valve function without long-term trade-offs in THV performance or structural valve damage, as demonstrated in bench studies simulating up to 5 years of valve wear.#EIJBestOf @David_Meier_ @sellers_steph 👉ow.ly/hlwg50Sy4gM
1
20
47
5,614
Mark F. Sasse retweeted
You may have heard of the "5-6-7-8" rule for LM-LAD-LCx stent MSAs to reduce long term MACE, but this new study in @CircIntv suggests that bigger MSAs are needed. A new "6-8-12" rule? ahajournals.org/doi/10.1161/…).
7
143
358
36,969
Mark F. Sasse retweeted
Patient was referred to our centre for CABG due to significant proximal and mid LAD disease. Review of diagnostic angio showed this. What do you think might have happened here
15
18
68
29,857
Mark F. Sasse retweeted
Anticoagulation with #DOACs vs. #VKAs in patients with left #ventricular thrombus: a new meta-analysis just published in #EHJPharmacotherapy 💊 bit.ly/3yVn3Gi @EditorEHJCVP @FeliceGragnano @DrErikGrove @GianluSava @jpkaski
3
76
174
28,585
Mark F. Sasse retweeted
Contemporary issues of percutaneous coronary intervention in heavily calcified chronic total occlusions: an expert review from the European CTO Club. #EIJBestOf ow.ly/8qaG50OGpNo
61
158
19,062
Mark F. Sasse retweeted
🔴🔥Simple diagnostic criteria for HFpEF ✅A score of 6 or more is highly suggestive of HFpEF! jacc.org/doi/epdf/10.1016/j.… #cardiovascular #medx #MedEd #CardioTwitter #CardioEd #Meded #medEd #cardiotwiteros #MedX #MedTwitter #cardiotwitter #medtwitterWhat #medical #cardiox
1
171
637
83,522
Mark F. Sasse retweeted
In the REVIVED-BCIS2 (Revascularization for Ischemic Ventricular Dysfunction) trial, PCI did not reduce the incidence of death or hospitalization for heart failure (HHF). Similarly, in a recent prespecified secondary analysis, PCI did not improve the hierarchical composite of death, HHF, and health status at 2 years. PCI improved KCCQ-OSS at 6 months, but this benefit was not sustained to 1- or 2-year follow-up jacc.org/doi/10.1016/j.jchf.… @JACCJournals
1
26
61
11,743
Mark F. Sasse retweeted
6 May 2024
Warning: for novice US DCB users! DCB are not non compliant! Here is a perforation i had with a 3.5 DCB after taking it to its nominal 14 Bar pressure( it grew to 4) after an uneventful NC PTCA using NC quantum 3.5/15 at 28 Bar! Watch ur size chart!
15
22
91
24,691
Mark F. Sasse retweeted
Do you "wedge" the PA catheter in the CICU because you don't trust the surrogate PA diastolic? Compelling safety reasons to avoid doing this. A new study in @JCardFail validating the use of PA diastolic for most patients with left-sided predominant CS. onlinejcf.com/article/S1071-…

5
20
87
12,897
Very important question!
We’re coming closer to enrollment completion for the #STAR trial led by Taishi Hirai & @KateKearney4. Hopefully it’ll confirm the safety and efficacy of a 2-step #CTO recanalization in case of impending failure or to avoid risky epicardial collaterals, like this one 👇🏻.
1
250
Mark F. Sasse retweeted
29 Dec 2023
Update data from a post hoc secondary analysis of the #STRONG-HF trial 📍In 515 patients, over 90% received medium-to-high doses of #GDMT just 2 weeks post-discharge. 📍⤵️ readmission and death rates in 6 months better #QoL 📍Rapidly optimizing doses of 4 pillars HF meds was feasible and safe in most patients, and crucial for better outcomes in #AHF patients. jamanetwork.com/journals/jam… @JAMACardio #HeartFailure
4
19
52
6,187
Mark F. Sasse retweeted
Amiodarone for atrial fibrillation: a dead man walking? Read the latest editorial in #EHJ. doi.org/10.1093/eurheartj/eh… #amiodarone #AF ##cardiotwitter @ESC_Journals @escardio
2
48
148
15,422
Mark F. Sasse retweeted
Unexpectedly “fished”🐠 this out of the LV apex during Impella CP removal. Patient recovering from large anterior MI with apical akinesis. Incredibly lucky; no clinical signs of embolization! 🍀 😬@SandeepNathanMD @Babar_Basir @ShashankSinhaMD @VorovichHeartMD @BurkhoffMd @NavinKapur4 @Abiomed @TheRealDoctorOs @SGuptaMD
8
14
88
13,080
Mark F. Sasse retweeted
Sirolimus vs Paclitaxel DCBs.
2
16
65
5,032
Mark F. Sasse retweeted
An excellent way to cross retrogradely is to telescope an angled glide catheter through 6F and cross it using a straight wire. Learned from ⁦@tjsimard⁩. ⁦@benhibbertMDPhD
7
5
44
9,577
Mark F. Sasse retweeted
Do you know the presentation, management, and outcomes of very late sinus sequestration in native aortic annuli? If not, learn about it in #JACCCaseReports: bit.ly/3ZPN4Ai #TAVI #TAVR #CardioTwitter
12
36
27,865